TARS CIK: 1819790

Tarsus Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
55.0
FY22:
24.9
FY23:
15.9
FY24:
170
FY25:
421
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−63.7
FY23:
−145
FY24:
−121
FY25:
−71.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−58.9
FY23:
−132
FY24:
−104
FY25:
−54.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−62.1
FY23:
−136
FY24:
−116
FY25:
−64.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−62.1
FY23:
−136
FY24:
−116
FY25:
−66.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data